ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Children and Adults With Neurofibromatosis Type 1 (NF1)-Associated Symptomatic Plexiform Neurofibroma (PN) (S29.003)

Overview of attention for article published in Neurology, April 2025

Altmetric Badge

Mentioned by

bluesky: 1 Bluesky user

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 1 Bluesky post from an account with 123 followers.

ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Children and Adults With Neurofibromatosis Type 1 (NF1)-Associated Symptomatic Plexiform Neurofibroma (PN) (S29.003)

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.